Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal

Lynda Cheddani1,2, Jean Philippe Haymann3,4, Sophie Liabeuf5,6

  • 1Université Paris Saclay (Paris Sud et Versailles Saint Quentin en Yvelines), INSERM U1018, Equipe 5, CESP (Centre de Recherche en Épidémiologie et Santé des Populations), France.

Insights

Kidney transplant recipients (KTRs) show reduced aortic stiffness one year post-transplant compared to chronic kidney disease patients (CKDps). This suggests different cardiovascular disease pathways in KTRs versus CKD.

Area of Science:

  • Cardiovascular Science
  • Nephrology
  • Transplantation Medicine

Background:

  • Chronic kidney disease (CKD) presents a significant cardiovascular risk.
  • Kidney transplant recipients (KTRs) face a higher global mortality risk than matched CKD patients.
  • Aortic stiffness, measured by carotid-femoral pulse wave velocity (CF-PWV), is a key cardiovascular risk indicator.

Purpose of the Study:

  • To compare aortic stiffness (CF-PWV) in KTRs versus CKD patients with similar measured glomerular filtration rates (mGFR).
  • To evaluate cardiovascular risk factors associated with arterial stiffness in these patient groups.

Main Methods:

  • Two cohorts, TransplanTest (KTRs) and NephroTest (CKDps), were analyzed for CF-PWV.
  • Propensity score matching was used, considering mGFR, age, sex, mean blood pressure (MBP), body mass index (BMI), and heart rate.
  • Logistic regression identified factors associated with high arterial stiffness (CF-PWV > 10.6 m/s).

Main Results:

  • At 12 months post-transplant, KTRs exhibited significantly lower CF-PWV (10.1 m/s) than CKDps (11.0 m/s).
  • The prevalence of high arterial stiffness was lower in KTRs (38.0%) compared to CKDps (57.1%).
  • High arterial stiffness was linked to lower mGFR, older age, higher BMI, higher MBP, diabetes, and elevated parathyroid hormone levels.

Conclusions:

  • Aortic stiffness is significantly reduced in KTRs one year after transplantation compared to GFR-matched CKD patients.
  • These findings suggest distinct pathophysiological mechanisms for cardiovascular disease in KTRs compared to CKD.
  • This highlights potential benefits of kidney transplantation in mitigating cardiovascular risk.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
104
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
108
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
122
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
300
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
224
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
42